Advances in cellular therapy for the treatment of thyroid cancer.
Jul 2010 - J Oncol; 2010:1687-8469 [PMID:20671939]
[Papewalis C] [Ehlers M] [Schott M]

Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma.
May 2009 - Oncol. Rep.; 21(6):1021-335X [PMID:19424640]
[Bachleitner-Hofmann T] [Friedl J] [Hassler M] [Hayden H] [Dubsky P] [Sachet M] [Rieder E] [Pfragner R] [Brostjan C] [Riss S] [Niederle B] [Gnant M] [Stift A]

Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer.
Jul 2008 - Clin. Cancer Res.; 14(13):1078-0432 [PMID:18594013]
[Papewalis C] [Wuttke M] [Seissler J] [Meyer Y] [Kessler C] [Jacobs B] [Ullrich E] [Willenberg HS] [Schinner S] [Baehring T] [Scherbaum WA] [Schott M]

Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma.
Feb 2008 - Horm. Metab. Res.; 40(2):0018-5043 [PMID:18283628]
[Papewalis C] [Wuttke M] [Jacobs B] [Domberg J] [Willenberg H] [Baehring T] [Cupisti K] [Raffel A] [Chao L] [Fenk R] [Seissler J] [Scherbaum WA] [Schott M]

Results of a phase I clinical study using dendritic cell vaccinations for thyroid cancer.
Feb 2007 - Thyroid; 17(1):1050-7256 [PMID:17274750]
[Kuwabara K] [Nishishita T] [Morishita M] [Oyaizu N] [Yamashita S] [Kanematsu T] [Obara T] [Mimura Y] [Inoue Y] [Kaminishi M] [Kaga K] [Amino N] [Kitaoka M] [Ito K] [Miyauchi A] [Noguchi S] [Uchimaru K] [Akagawa E] [Watanabe N] [Takahashi TA] [Sato K] [Inazawa T] [Nakaoka T] [Yamashita N]

Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma.
Nov 2006 - J. Clin. Endocrinol. Metab.; 91(11):0021-972X [PMID:16954161]
[Bachleitner-Hofmann T] [Strohschneider M] [Krieger P] [Sachet M] [Dubsky P] [Hayden H] [Schoppmann SF] [Pfragner R] [Gnant M] [Friedl J] [Stift A]

Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers.
Sep 2006 - Endocr. Relat. Cancer; 13(3):1351-0088 [PMID:16954430]
[Schott M]

Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination.
Nov 2005 - Anticancer Res.; 25(6B):0250-7005 [PMID:16309220]
[Pfragner R] [Skofitsch G] [Höger H] [Jech M] [Rinner B] [Siegl V] [Niederle B] [Gnant M] [Friedl J] [Stift A]

Dendritic cell vaccination in medullary thyroid carcinoma.
May 2004 - Clin. Cancer Res.; 10(9):1078-0432 [PMID:15131029]
[Stift A] [Sachet M] [Yagubian R] [Bittermann C] [Dubsky P] [Brostjan C] [Pfragner R] [Niederle B] [Jakesz R] [Gnant M] [Friedl J]

Thyroglobulin-pulsed human monocyte-derived dendritic cells induce CD4+ T cell activation.
Dec 2003 - Int. J. Mol. Med.; 13(1):1107-3756 [PMID:14654967]
[Morishita M] [Uchimaru K] [Sato K] [Ohtsuru A] [Yamashita S] [Kanematsu T] [Yamashita N]

Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells.
Mar 2002 - J. Clin. Endocrinol. Metab.; 87(3):0021-972X [PMID:11889172]
[Bachleitner-Hofmann T] [Stift A] [Friedl J] [Pfragner R] [Radelbauer K] [Dubsky P] [Schüller G] [Benkö T] [Niederle B] [Brostjan C] [Jakesz R] [Gnant M]

Hyperthermia inhibits proliferation and stimulates the expression of differentiation markers in cultured thyroid carcinoma cells.
Dec 1994 - Cancer Lett.; 87(1):0304-3835 [PMID:7954371]
[Trieb K] [Sztankay A] [Amberger A] [Lechner H] [Grubeck-Loebenstein B]